Syngene International Ltd SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Mar 21 | Dec 20 |
|---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Syngene International Ltd
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
SYNGENE News
- ARVIND SMARTSPACES LTD
- FOSECO INDIA LTD.
- NEWGEN SOFTWARE TECHNOLOGIES LIMITED
- JOHNSON CONTROLS-HITACHI AIR CONDITIONING INDIA LTD
- JAGATJIT INDUSTRIES LTD.
- EON ELECTRIC LTD.
- AASWA TRADING & EXPORTS LTD.
- BEST EASTERN HOTELS LTD.
- NYSSA CORPORATION LIMITED
- WESTERN MINISTIL LTD.
- DECO-MICA LTD.
- JUMBO FINANCE LTD.
- NOBLE EXPLOCHEM LTD.
- MOUNT SHIVALIK INDUSTRIES LTD.
- GKW LIMITED
- BHARAT FORGE LTD
- SHEELA FOAM LTD
- BETEX INDIA LTD.
- UMA EXPORTS LTD
- BEARDSELL LTD
Frequently Asked Questions
What is the Share price of Syngene International Ltd (SYNGENE)?
Can I buy Syngene International Ltd (SYNGENE) shares?
How do I buy Syngene International Ltd (SYNGENE) from Angel One?
- Direct investment: You can buy Syngene International Ltd (SYNGENE) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Syngene International Ltd (SYNGENE) shares.
In which sector do Syngene International Ltd (SYNGENE) belong?
About SYNGENE
Today's live share price for Syngene International Ltd is NSE: ₹ 560.60, BSE: ₹ 559.85 with a current market capitalization of .
Syngene International Limited is an internationally reputed contract research and manufacturing organisation with multidisciplinary skills in chemistry and biology services. The company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited. The company was formed with objectives of providing contract research service to overseas customer in the field of synthetic chemistry, molecular biology and custom synthesis. The company was incorporated at Bangalore in the year 1993. During the year 1994-1995, the company pioneered in CRO services for both Chemistry and Biology. During the year 2001-2002, the company acquired a new facility inclusive of a cGMP pilot plant. In March 30, 2002, the company`s 99.9% equity share was transferred to Biocon and the company became a subsidiary of Biocon Ltd. During the year 2003-2004, the company introduced Process Research and Optimization Services. In October 21, 2004, the company commissioned a new research facility at Boammasandra, Bangalore. In February 15, 2006, the company commissioned new facility at Biocon Park. In August 30, 2006, the company received approval of additional facility to set up as SEZ unit from Cochin Special Economic Zone. During the year 2006-2007, Bristol- Myers Squibb had entered into a long term agreement with the company to set up an exclusive research facility to house more than 400 scientists. During the year, the company had ventured into other area of Biology viz Genetic Engineering, Protein Chemistry, and assay development. The company had developed extensive expertise in the creation of customized stable cell lines expressing proteins / receptors of intersest. During the year 2007-2008, the company entered a long term service agreement with BMS. During the year 2008-2009, the company created an alliance partnership with DuPont Crop Protection.
Read more
